Patient Capital Management’s Expedia Group EXPE Stock Holding History

Patient Capital Management’s Portfolio EXPE Stock Details EXPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$38.7M	Sell	167,784 -8,498	-5%	-$2.09M	1.42%	29
2025 Q4	$49.9M	Sell	176,282 -77,195	-30%	-$19.1M	1.93%	25
2025 Q3	$54.2M	Sell	253,477 -8,378	-3%	-$1.68M	2.17%	24
2025 Q2	$44.2M	Sell	261,855 -16,942	-6%	-$2.75M	1.99%	26
2025 Q1	$46.9M	Sell	278,797 -163,632	-37%	-$29.8M	2.41%	19
2024 Q4	$82.4M	Sell	442,429 -204,900	-32%	-$35.3M	3.8%	7
2024 Q3	$95.8M	Sell	647,329 -68,646	-10%	-$9.09M	4.7%	5
2024 Q2	$90.2M	Sell	715,975 -13,619	-2%	-$1.68M	4.79%	4
2024 Q1	$101M	Sell	729,594 -205,896	-22%	-$29.3M	4.89%	3
2023 Q4	$142M	Sell	935,490 -35,547	-4%	-$4.35M	7.52%	1
2023 Q3	$100M	Buy	971,037 +64,046	+7%	+$7.07M	5.87%	1
2023 Q2	$99.2M	Buy	906,991 +776,391	+594%	+$76.1M	5.52%	2
2023 Q1	$12.7M	Sell	130,600 -1,425	-1%	-$149K	5.64%	1
2022 Q4	$11.6M	Buy	132,025 +5,825	+5%	+$551K	5.62%	2
2022 Q3	$11.8M	Buy	126,200 +34,125	+37%	+$3.48M	5.9%	2
2022 Q2	$8.73M	Buy	+92,075	New	+$13M	3.87%	6

Other funds holding EXPE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WPL

WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Patient Capital Management's EXPE Position: Q1 2026 in Review

Patient Capital Management reduced its Expedia Group (EXPE) stake by 4.8% in Q1 2026, selling an estimated $2.09M and leaving 167,784 shares worth $38.7M. The position accounts for 1.42% of the portfolio, ranked #29.

Patient Capital Management first reported a position in EXPE in Q2 2022 and has held it in 16 quarters since. The position peaked at $142M in Q4 2023. 1,098 funds tracked by Wall St. Rank hold EXPE as of Q1 2026.

Patient Capital Management held 167,784 shares of Expedia Group worth $38.7M as of Q1 2026.
Patient Capital Management sold 8,498 Expedia Group shares in Q1 2026, an estimated $2.09M.
Expedia Group made up 1.42% of Patient Capital Management's portfolio in Q1 2026, its #29 holding.
Patient Capital Management first reported a position in Expedia Group in Q2 2022 and has held it in 16 quarters since.
Patient Capital Management's Expedia Group position peaked at $142M in Q4 2023.
1,098 funds tracked by Wall St. Rank held Expedia Group as of Q1 2026.

Based on Patient Capital Management's 13F filing for Q1 2026, filed 14 May 2026.